D614G and Omicron SARS-CoV-2 variant spike proteins differ in the effects of N-glycan modifications on spike expression, virus infectivity, and neutralization by some therapeutic antibodies
S. Lusvarghi, C. B. Stauft, R. Vassell, B. Williams, H. Baha, W. Wang, S. N. Neerukonda, T. Wang, C. D. Weiss
This study compares how N-glycan modifications affect spike expression, infectivity, and antibody neutralization in SARS-CoV-2 D614G and Omicron variants.
bioRxiv · May 10, 2023 · PreprintMicrobiology